Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$2.16B |
| 2 |
Hershey
HSY
|
+$663M |
| 3 |
Lockheed Martin
LMT
|
+$622M |
| 4 |
Altria Group
MO
|
+$525M |
| 5 |
Pfizer
PFE
|
+$499M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$2.76B |
| 2 |
Merck
MRK
|
+$2.35B |
| 3 |
Automatic Data Processing
ADP
|
+$1.57B |
| 4 |
Blackstone
BX
|
+$1.38B |
| 5 |
Illinois Tool Works
ITW
|
+$1.13B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.85% |
| 2 | Financials | 12.71% |
| 3 | Healthcare | 11.72% |
| 4 | Consumer Discretionary | 10.09% |
| 5 | Industrials | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1726
Schneider National
SNDR
$6.27B
| $16.2M | ﹤0.01% |
717,693
+59,605
| +9% | +$1.41M |
|
1727
Veracyte
VCYT
$3.7B
| $16.2M | ﹤0.01% |
732,775
+34,357
| +5% | +$838K |
|
1728
Columbus McKinnon
CMCO
$570M
| $16.2M | ﹤0.01% |
363,613
+5,780
| +2% | +$234K |
|
1729
Astrana Health
ASTH
$1.79B
| $16.2M | ﹤0.01% |
385,770
+41,741
| +12% | +$1.63M |
|
|
GOLD
1730
Gold.com Inc
GOLD
$1.22B
| $16.1M | ﹤0.01% |
525,918
+73,667
| +16% | +$2.03M |
|
1731
Mobileye
MBLY
$2.01B
| $16.1M | ﹤0.01% |
501,014
+78,630
| +19% | +$2.23M |
|
|
RYZ
1732
Ryerson Holding Corp
RYZ
$1.44B
| $16.1M | ﹤0.01% |
480,161
+35,685
| +8% | +$1.17M |
|
1733
Enterprise Financial Services Corp
EFSC
$2.43B
| $16.1M | ﹤0.01% |
396,051
-14,447
| -4% | -$592K |
|
|
STR
1734
DELISTED
Sitio Royalties
STR
| $16.1M | ﹤0.01% |
649,797
+11,787
| +2% | +$265K |
|
|
AHRT
1735
AH Realty Trust
AHRT
$532M
| $16M | ﹤0.01% |
1,543,004
-8,558
| -0.6% | -$97.1K |
|
1736
Gray Television
GTN
$429M
| $16M | ﹤0.01% |
2,536,587
+315,100
| +14% | +$2.41M |
|
1737
Apogee Therapeutics
APGE
$10.1B
| $16M | ﹤0.01% |
240,766
+85,001
| +55% | +$3.71M |
|
1738
Atlanta Braves Holdings Series B
BATRK
$3.28B
| $16M | ﹤0.01% |
409,348
+4,014
| +1% | +$158K |
|
1739
STAAR Surgical
STAA
$1.22B
| $15.9M | ﹤0.01% |
416,596
+26,759
| +7% | +$870K |
|
1740
Ecovyst
ECVT
$1.32B
| $15.9M | ﹤0.01% |
1,429,543
+55,438
| +4% | +$525K |
|
1741
Clear Channel Outdoor Holdings
CCO
$1.23B
| $15.9M | ﹤0.01% |
9,658,791
+5,263
| +0.1% | +$8.99K |
|
1742
Pathward Financial
CASH
$1.89B
| $15.9M | ﹤0.01% |
315,146
+7,769
| +3% | +$394K |
|
1743
Reynolds Consumer Products
REYN
$5.33B
| $15.8M | ﹤0.01% |
554,023
+17,703
| +3% | +$499K |
|
1744
First Busey Corp
BUSE
$2.59B
| $15.8M | ﹤0.01% |
656,784
+20,165
| +3% | +$473K |
|
1745
Metallus
MTUS
$818M
| $15.8M | ﹤0.01% |
708,790
+34,579
| +5% | +$721K |
|
1746
Monro
MNRO
$398M
| $15.8M | ﹤0.01% |
499,483
+33,052
| +7% | +$1.02M |
|
1747
Enviri
NVRI
$637M
| $15.7M | ﹤0.01% |
1,719,755
+56,654
| +3% | +$476K |
|
1748
Twist Bioscience
TWST
$5.97B
| $15.7M | ﹤0.01% |
457,935
+9,703
| +2% | +$350K |
|
1749
Upstart Holdings
UPST
$2.77B
| $15.7M | ﹤0.01% |
582,602
+9,426
| +2% | +$279K |
|
1750
Amphastar Pharmaceuticals
AMPH
$886M
| $15.6M | ﹤0.01% |
356,405
-23,075
| -6% | -$1.19M |
|
Similar funds
Charles Schwab's Q1 2024 Portfolio in Review
As of Q1 2024, Charles Schwab held 3,573 positions worth $433B, up 10% from $394B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Trading was light in Q1 2024: portfolio turnover was 3.8%. Charles Schwab opened 35 new positions and exited 102, leaving the 3,573-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q1 2024 buy was Schwab Fundamental US Large Company Index ETF: 3,608,604 shares worth $81.1M.
- Charles Schwab added most to Bristol-Myers Squibb in Q1 2024, an estimated $2.16B increase.
- Charles Schwab's biggest Q1 2024 reduction was Broadcom, cutting an estimated $2.76B.
- Charles Schwab fully exited Splunk Inc in Q1 2024, selling an estimated $104M.
- Charles Schwab's ten largest holdings make up 20% of its $433B portfolio in Q1 2024.
- Charles Schwab opened 35 new positions and closed 102 in Q1 2024.
- Charles Schwab's portfolio value rose 10% quarter-over-quarter to $433B.
Based on Charles Schwab's 13F filing for Q1 2024, filed 9 May 2024.